Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer.

Weiss J, Afghahi A, Shagisultanova E, Diamond JR.

Oncology (Williston Park). 2018 Oct 15;32(10):513-5. No abstract available.


Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients.

Rafat M, Aguilera TA, Vilalta M, Bronsart LL, Soto LA, von Eyben R, Golla MA, Ahrari Y, Melemenidis S, Afghahi A, Jenkins MJ, Kurian AW, Horst KC, Giaccia AJ, Graves EE.

Cancer Res. 2018 Aug 1;78(15):4241-4252. doi: 10.1158/0008-5472.CAN-17-3623. Epub 2018 Jun 7.


Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW.

Clin Cancer Res. 2018 Jun 15;24(12):2851-2858. doi: 10.1158/1078-0432.CCR-17-1323. Epub 2018 Mar 26.


The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.

Afghahi A, Kurian AW.

Curr Treat Options Oncol. 2017 May;18(5):27. doi: 10.1007/s11864-017-0468-y. Review.


Genetics of triple-negative breast cancer: Implications for patient care.

Afghahi A, Telli ML, Kurian AW.

Curr Probl Cancer. 2016 Mar - Aug;40(2-4):130-140. doi: 10.1016/j.currproblcancer.2016.09.007. Epub 2016 Sep 23. Review.


Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.

Afghahi A, Timms KM, Vinayak S, Jensen KC, Kurian AW, Carlson RW, Chang PJ, Schackmann E, Hartman AR, Ford JM, Telli ML.

Clin Cancer Res. 2017 Jul 1;23(13):3365-3370. doi: 10.1158/1078-0432.CCR-16-2174. Epub 2017 Jan 13.


Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.

Afghahi A, Mathur M, Thompson CA, Mitani A, Rigdon J, Desai M, Yu PP, de Bruin MA, Seto T, Olson C, Kenkare P, Gomez SL, Das AK, Luft HS, Sledge GW Jr, Sing AP, Kurian AW.

J Oncol Pract. 2016 Jun;12(6):e697-709. doi: 10.1200/JOP.2015.009803. Epub 2016 May 24.


Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer.

Afghahi A, Forgó E, Mitani AA, Desai M, Varma S, Seto T, Rigdon J, Jensen KC, Troxell ML, Gomez SL, Das AK, Beck AH, Kurian AW, West RB.

Breast Cancer Res. 2015 Aug 13;17:108. doi: 10.1186/s13058-015-0623-y.


Targeted Therapy for Cancer in the Genomic Era.

Afghahi A, Sledge GW Jr.

Cancer J. 2015 Jul-Aug;21(4):294-8. doi: 10.1097/PPO.0000000000000135. Review.


Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement.

Dinner S, Witteles W, Afghahi A, Witteles R, Arai S, Lafayette R, Schrier SL, Liedtke M.

Haematologica. 2013 Oct;98(10):1593-9. doi: 10.3324/haematol.2013.084574. Epub 2013 May 28.


More than a frog in the throat: a case series and review of localized laryngeal amyloidosis.

Stevenson R, Witteles R, Damrose E, Arai S, Lafayette RA, Schrier S, Afghahi A, Liedtke M.

Arch Otolaryngol Head Neck Surg. 2012 May;138(5):509-11. doi: 10.1001/archoto.2012.423. Review. No abstract available.


[Larval development of Angiostrongylus vasorum (Baillet, 1866) in the body of various species of terrestrial mollusks].

Guilhon J, Afghahi A.

C R Acad Sci Hebd Seances Acad Sci D. 1969 Jan 13;268(2):434-6. French. No abstract available.


Supplemental Content

Loading ...
Support Center